119 related articles for article (PubMed ID: 37122167)
21. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.
Xue D; Li D; Dou C; Li J
Dis Markers; 2021; 2021():4739868. PubMed ID: 34925644
[TBL] [Abstract][Full Text] [Related]
22. Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma.
Wang N; Liu D
Onco Targets Ther; 2021; 14():5373-5383. PubMed ID: 34880629
[TBL] [Abstract][Full Text] [Related]
23. Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs.
Xu C; Chen Z; Pan X; Liu M; Cheng G; Li J; Mei Y
Appl Biochem Biotechnol; 2022 Dec; 194(12):6255-6269. PubMed ID: 35904674
[TBL] [Abstract][Full Text] [Related]
24. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
[TBL] [Abstract][Full Text] [Related]
25. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
26. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
27. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract][Full Text] [Related]
28. Development of a prognostic metabolic signature in stomach adenocarcinoma.
Gong Y; Wu S; Dong S; Chen S; Cai G; Bao K; Yang H; Jiao Y
Clin Transl Oncol; 2022 Aug; 24(8):1615-1630. PubMed ID: 35355155
[TBL] [Abstract][Full Text] [Related]
29. GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma.
Ni L; Chen S; Liu J; Li H; Zhao H; Zheng C; Zhang Y; Huang H; Huang J; Wang B; Lin C
Mediators Inflamm; 2023; 2023():7123568. PubMed ID: 37124060
[TBL] [Abstract][Full Text] [Related]
30. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
Guo Y; Wang ZW; Su WH; Chen J; Wang YL
Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
[TBL] [Abstract][Full Text] [Related]
32. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma.
Xu Z; Xiang L; Peng L; Gu H; Wang Y
Comput Math Methods Med; 2022; 2022():3445230. PubMed ID: 36148016
[TBL] [Abstract][Full Text] [Related]
34. A novel risk score model for stomach adenocarcinoma based on the expression levels of 10 genes.
Guan E; Tian F; Liu Z
Oncol Lett; 2020 Feb; 19(2):1351-1367. PubMed ID: 31966067
[TBL] [Abstract][Full Text] [Related]
35. Sarcopenia and a 5-mRNA risk module as a combined factor to predict prognosis for patients with stomach adenocarcinoma.
Yang H; Tian W; Zhou B
Genomics; 2022 Jan; 114(1):361-377. PubMed ID: 34933074
[TBL] [Abstract][Full Text] [Related]
36. A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma.
Chen B; Yao Y; Mao D; Li C; Wang X; Sheng S; Zhang L; Wang X; Chen S; Xu W; Deng J; Sun C; Zhou Q; Lowe S; Bentley R; Shao W; Li H
Front Immunol; 2022; 13():928742. PubMed ID: 35935979
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of the immune and prognostic implication of MASP1 in stomach adenocarcinoma.
Zhang CH; Xu ZQ; Peng LL; Wang JJ; Gu HT
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6725-6741. PubMed ID: 36196721
[TBL] [Abstract][Full Text] [Related]
38. A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma.
Liu J; Tan Z; Yang S; Song X; Li W
Aging (Albany NY); 2022 Sep; 14(17):7170-7185. PubMed ID: 36103249
[TBL] [Abstract][Full Text] [Related]
39. Analysis of expression profile of miRNA in stomach adenocarcinoma.
Huo Q
J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
[TBL] [Abstract][Full Text] [Related]
40. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
